TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
Biomedica Norden AB
Closing information (x1000 EUR)
| Closing information | 2023/12 | 2022/12 | 2021/12 |
| Turnover |
407
|
412
|
447 |
| Financial expenses |
15
|
11
|
14 |
| Earnings before taxes |
-4
|
-5
|
-2 |
| EBITDA |
56
|
50
|
62 |
| Total assets |
212
|
248
|
319 |
| Current assets |
81
|
72
|
80 |
| Current liabilities |
36
|
68
|
127 |
| Equity capital |
31
|
35
|
44 |
| - share capital |
9
|
9
|
10 |
| Employees (average) |
1
|
2
|
2 |
Financial ratios
| Fiscal year | 2023/12 | 2022/12 | 2021/12 |
| Solvency |
14.6%
|
14.1%
|
13.8% |
| Turnover per employee |
407
|
206
|
224 |
| Profit as a percentage of turnover |
-1.0%
|
-1.2%
|
-0.4% |
| Return on assets (ROA) |
5.2%
|
2.4%
|
3.8% |
| Current ratio |
225.0%
|
105.9%
|
63.0% |
| Return on equity (ROE) |
-12.9%
|
-14.3%
|
-4.5% |
| Change turnover |
-6
|
1
|
60 |
| Change turnover % |
-1%
|
0%
|
15% |
| Chg. No. of employees |
-1
|
0
|
0 |
| Chg. No. of employees % |
-50%
|
0%
|
0% |
Total value of public sale
| Fiscal year | 2023/12 | 2022/12 | 2021/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.